Skip to main content
SpringerLink
Log in

Development of Clinical Trial of E1A Gene Therapy Targeting HER-2/neu-overexpressing Breast and Ovarian Cancer

  • Chapter
  • First Online:
Cancer Gene Therapy

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 465))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bargmann, C.I., Hung, M.C., and Weinberg, R.A. (1986a). Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell, 45, 649–657.

    Article  PubMed  CAS  Google Scholar 

  • Bargmann, C.I., Hung, M.C., and Weinberg, R.A. (1986b). The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature, 319, 226–230.

    Article  PubMed  CAS  Google Scholar 

  • Bargmann, C.I., and Weinberg, R.A. (1988). Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene. Proc Natl Acad Sci USA, 85, 5394–5398.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Benz, C.C., Scott. G.K., Sarup, J.C., Johnson, R.M., Tripathy, D., Coronado, E., Shepard, H.M., and Osborne, C.K. (1993). Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu. Breast Cancer Res Treat, 24, 85–95.

    Article  CAS  Google Scholar 

  • Berchuck, A., Kamel, A., Whitaker, R., Kerns, B., Olt, G., Kinney, R., Soper, J.T., Dodge, R., Clarke-Pearson, D.L., Marks, P., et al. (1990). Overexpression of Her-2/Neu Is Associated With Poor Survival in Advanced Epithelial Ovarian Cancer. Cancer Research, 50, 4087–4091.

    PubMed  CAS  Google Scholar 

  • Byrd, P.J., Grand, R.J., and Gallimore, P.H. (1988). Differential transformation of primary human embryo retinal cells by adenovirus E1 regions and combinations of E1A + Ras. Oncogene, 2, 477–484.

    PubMed  CAS  Google Scholar 

  • Chang, J.Y., Xia, W., Shao, R., Sorgi, E, Hortobagyi, G.N., Huang, L., and Hung, M.C. (1997). The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer. Oncogene, 14, 561–568.

    Article  PubMed  CAS  Google Scholar 

  • Chang, J.Y., Xia, W.Y., Shao, R.P., and Hung, M.C. (1996). Inhibition of intratracheal lung cancer development by systemic delivery of E1A. Oncogene, 13, 1405–1412.

    PubMed  CAS  Google Scholar 

  • Chazin, V.R., Kaleko, M., Miller, A.D., and Slamon, D.J. (1992). Transformation Mediated By the Human Her-2 Gene Independent of the Epidermal Growth Factor Receptor. Oncogene, 7, 1859–1866.

    PubMed  CAS  Google Scholar 

  • Chen, H., Yu, D., Chinnadurai, G., Karunagaran, D., and Hung, M.C. (1997). Mapping of adenovirus 5 E1A domains responsible for suppression of neu-mediated transformation via transcriptional repression of neu. Oncogene, 14, 1965–1971.

    Article  PubMed  CAS  Google Scholar 

  • Chinnadurai, G. (1992). Adenovirus E1a as a tumor-suppressor gene. Oncogene, 7, 1255–1258.

    PubMed  CAS  Google Scholar 

  • Deng, J., Xia, W., and Hung, M.C. (1998). Adenovirus 5 E1A-mediated tumor suppression associated with ElA-mediated apoptosis in vivo. Oncogene, 17, 2167–2175.

    Article  PubMed  CAS  Google Scholar 

  • Frisch, S.M. (1991). Antioncogenic effect of adenovirus ela in human tumor cells. Proc Nail Acad Sci USA, 88, 9077–9081.

    Article  CAS  Google Scholar 

  • Frisch, S.M., and Dolter, K.E. (1995). Adenovirus E1a-mediated tumor suppression by a c-erbB-2/neu-independent mechanism. Cancer Research, 55, 5551–5555.

    PubMed  CAS  Google Scholar 

  • Hung, M.C., Schechter, A.L., Chevray, P.Y., Stern, D.F., and Weinberg, R.A. (1986). Molecular cloning of the neu gene: absence of gross structural alteration in oncogenic alleles. Proc Nail Acad Sci USA, 83, 261–264.

    Article  CAS  Google Scholar 

  • Hung, M.C., Yan, D.H., and Zhao, X.Y. (1989). Amplification of the proto-neu oncogene facilitates oncogenic activation by a single point mutation. Proc Natl Acad Sci USA, 86, 2545–2548.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Kameda, T., Yasui, W., Yoshida, K., Tsujino, T., Nakayama, H., Ito, M., Ito, H., and Tahara, E. (1990). Expression of erbb2 in human gastric carcinomas: relationship between p185erbb2 expression and the gene amplification. Cancer Research, 50, 8002–8009.

    PubMed  CAS  Google Scholar 

  • Kern, J.A., Schwartz, D.A., Nordberg, J.E., Weiner, D.B., Greene, M.I., Torney, L., and Robinson, R.A. (1990). p185neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Research, 50, 5184–5187.

    PubMed  CAS  Google Scholar 

  • Kiyokawa, N., Yan, D.H., Brown, M.E., and Hung, M.C. (1995). Cell cycle-dependent regulation of p185neu: a relationship between disruption of this regulation and transformation. Proc Natl Acad Sci USA, 92, 1092–1096.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Lowe, S.W., Jacks, T., Housman, D.E., and Ruley, H.E. (1994). Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proc Natl Acad Sci USA, 91, 2026–2030.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Lowe, S.W., and Ruley, H.E. (1993a). Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev, 7, 535–545.

    Article  PubMed  CAS  Google Scholar 

  • Lowe, S.W., Ruley, H.E., Jacks, T., and Housman, D.E. (1993b). p53-dependent apoptosis modulates the cyto-toxicity of anticancer agents. Cell, 74, 957–967.

    Article  PubMed  CAS  Google Scholar 

  • Montell, C., Courtois, G., Eng, C., and Berk, A. (1984). Complete transformation by adenovirus 2 requires both E1A proteins. Cell, 36, 951–961.

    Article  PubMed  CAS  Google Scholar 

  • Murray, J.L., Yoo, G.H., Lopez-Berestein, G., Hung, M.-C, Booser, D., Rahman, Z., Valero, V., Hortobagyi, J., Ensley, J., Jacobs, J., Brewer, H., Carey, R., and Daifuku, R. (1998). Phase I trial of intratumoral liposomal-E1A gene therapy in patients with recurrent/refractory breast (BC) and head and neck (H&N) cancer. In Proc Annu Meet Am Soc Clin Oncol, Vol. 17. pp. 431a.

    Google Scholar 

  • Mymryk, J.S. (1996). Tumor suppressive properties of the adenovirus 5 E1A oncogene. Oncogene, 13, 1581–1589.

    PubMed  CAS  Google Scholar 

  • Nabel, E.G., Gordon, D., Yang, Z.Y., Xu, L., San, H., Plautz, G.E., Wu, B.Y., Gao, X., Huang, L., and Nabel, G.J. (1992). Gene transfer in vivo with DNA-liposome complex: lack of autoimmunity and gonadal localization. Hum Gene Ther, 3, 649–656.

    Article  PubMed  CAS  Google Scholar 

  • Nabel, G.J., Nabel, E.G., Yang, Z.Y., Fox, B.A., Plautz, G.E., Gao, X., Huang, L., Shu, S., Gordon, D., and Chang, A.E. (1993). Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci USA, 90, 11307–11311.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Nevins, J.R. (1990). Adenovirus E1A-dependent trans-activation of transcription. Semin Cancer Biol, 1, 59–68.

    PubMed  CAS  Google Scholar 

  • Nevins, J.R., Raychaudhuri, P., Yee, A.S., Rooney, R.J., Kovesdi, I., and Reichel, R. (1988). Transactivation by the adenovirus E1A gene. Biochem Cell Biol, 66, 578–583.

    Article  PubMed  CAS  Google Scholar 

  • Pegram, M.D., Finn, R.S., Arzoo, K., Beryl, M., Pietras, R.J., and Slamon, D.J. (1997). The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells. Oncogene, 15, 537–547.

    Article  PubMed  CAS  Google Scholar 

  • Pozzatti, R., McCormick, M., Thompson, M.A., and Khoury, G. (1988). The E1A gene of adenovirus type 2 reduces the metastatic potential of ras-transformed rat embryo cells. Mol Cell Biol, 8, 2984–2988.

    PubMed  PubMed Central  CAS  Google Scholar 

  • Ruley, H.E. (1983). Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature, 304, 602–606.

    Article  PubMed  CAS  Google Scholar 

  • Schechter, A.L., Hung, M.C., Vaidyanathan, L., Weinberg, R.A., Yang, F.T., Francke, U., Ullrich, A., and Coussens, L. (1985). The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science, 229, 976–978.

    Article  PubMed  CAS  Google Scholar 

  • Schneider, P.M., Hung. M.C., Chiocca, S.M., Manning, J., Zhao, X.Y., Fang, K., and Roth, J.A. (1989). Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer. Cancer Res, 49, 4968–1971.

    PubMed  CAS  Google Scholar 

  • Shao, R., Karunagaran, D., Zhou, B.P., Li, K., Lo, S.S., Deng, J., Chiao, P., and Hung, M.C. (1997). Inhibition of nuclear factor-kappaB activity is involved in E1A-mediated sensitization of radiation-induced apoptosis. J Biol Chem, 272, 32739–32742.

    Article  PubMed  CAS  Google Scholar 

  • Shi, D., He, G., Cao, S., Pan, W., Zhang, H.Z., Yu, D., and Hung. M.C. (1992). Overexpression of the c-erbB-2/neu-encoded p185 protein in primary lung cancer. Mol Carcinog, 5, 213–218.

    Article  PubMed  CAS  Google Scholar 

  • Shih, C., Padhy, L.C., Murray, M., and Weinberg, R.A. (1981). Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature, 290, 261–264.

    Article  PubMed  CAS  Google Scholar 

  • Slamon, D.J., Clark, G.M., Wong, S.G., Levin, W.J., Ullrich, A., and McGuire, W.J. (1987). Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 235, 177–182.

    Article  PubMed  CAS  Google Scholar 

  • Slamon, D.J., Godolphin, W., Jones, L.A., Holt, J.A., Wong, S.G., Keith, D.E., Levin, W.J., Stuart, S.G., Udove, J., Ullrich, A., and Press, M.F (1989). Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science, 244, 707–712.

    Article  PubMed  CAS  Google Scholar 

  • Stern, D.F., Kamps, M.P., and Cao, H. (1988). Oncogenic activation of p185neu stimulates tyrosine phosphorylation in vivo. Mol Cell Biol, 8, 3969–3973.

    PubMed  PubMed Central  CAS  Google Scholar 

  • Tan, M., Yao, J., and Yu, D. (1997). Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities. Cancer Research, 57, 1199–1205.

    PubMed  CAS  Google Scholar 

  • Tsai, CM., Perng, R.P., Chen, M.H., Jan, Y.H., Hung, M.C, Ku, T.Y., and Chang, K.T. (1994). Greater enhancement of chemosensitivity by caffeine in high-p185neu-expressing human non-small-cell lung cancer cell lines. J Natl Cancer Inst, 86, 1018–1020.

    Article  PubMed  CAS  Google Scholar 

  • Tsai, C.M., Yu, D., Chang, K.T., Wu, L.H., Perng, R.P., Ibrahim, N.K., and Hung. M.C. (1995). Enhanced chemoresistance by elevation of p185neu levels in HER-2/neu-transfected human lung cancer cells. J Null Cancer Inst, 87, 682–684.

    Article  CAS  Google Scholar 

  • Ueno, N.T., Yu, D., and Hung, M.C. (1997). Chemosensitization of HER-2/neu-overexpressing human breast cancer cells to paclitaxel (Taxol) by adenovirus type 5 E1A. Oncogene, 15, 953–960.

    Article  PubMed  CAS  Google Scholar 

  • Weiner, D.B., Nordberg, J., Robinson, R., Nowell, P.C., Gazdar, A.. Greene, M.I., Williams, W.V., Cohen, J.A., and Kern, J.A. (1990). Expression of the neu gene-encoded protein (p185neu) in human non-small cell carcinomas of the lung. Cancer Research, 50, 421–425.

    PubMed  CAS  Google Scholar 

  • Xia, W.Y., Lau, Y.K., Zhang. H.Z., Liu, A.R., Li. L., Kiyokawa, N., Clayman, G.L., Katz, R.L., and Hung, M.C. (1997). Strong correlation between c-Erbb-2 overexpression and overall survival of patients with oral squamous cell carcinoma. Clin Cancer Res, 3, 3–9.

    PubMed  CAS  Google Scholar 

  • Xing, X., Liu, V., Xia, W., Stephens, L.C., Huang, L., Lopez-Berestein, G., and Hung, M.C. (1997). Safety studies of the intraperitoneal injection of E1A-liposome complex in mice. Gene Ther, 4, 238–243.

    Article  PubMed  CAS  Google Scholar 

  • Xing, X., Zhang, S., Chang, J.Y., Tucker, S.D., Chen, H., Huang, L., and Hung, M.C. (1998). Safety study and characterization of E1A-liposome complex gene delivery in an ovarian cancer model. Gene Ther, 5, 1538–1544.

    Article  PubMed  CAS  Google Scholar 

  • Yamamoto, T., Ikawa, S., Akiyama, T., Semba, K., Nomura, N., Miyajima, N., Saito, T., and Toyoshima, K. (1986). Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature, 319, 230–234.

    Article  PubMed  CAS  Google Scholar 

  • Yan, D.H., Chang, L.S., and Hung, M.C. (1991). Repressed expression of the HER-2/c-erbB-2 proto-oncogene by the adenovirus E1a gene products. Oncogene, 6, 343–345.

    PubMed  CAS  Google Scholar 

  • Yokota, J., Yamamoto, T, Toyoshima, K., Terada, M., Sugimura, T, Battifora, H., and Cline, M.J. (1986). Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo. Lancet, 1, 765–767.

    Article  PubMed  CAS  Google Scholar 

  • Yoo, G.H., Ensley, J., Jacobs, J., Sakr, W., Johnson, R., Wei, W.Z., Carey, M., and Daifuku, R. (1998). Intratumoral El A gene therapy for patients with unresectable and recurren head and neck cancer. In Proc Annu Meet Am Assoc Cancer Res, Vol. 39. p. 322.

    Google Scholar 

  • Yu, D., Hamada, J., Zhang, H., Nicolson, G.L., and Hung, M.C. (1992). Mechanisms of c-erbB2/neu oncogene-induced metastasis and repression of metastatic properties by adenovirus 5 E1A gene products. Oncogene, 7, 2263–2270.

    PubMed  CAS  Google Scholar 

  • Yu, D., and Hung, M.C. (1998a). The erbB2 gene as a cancer therapeutic target and the tumor-and metasta-sis-suppressing function of E1A. Cancer Metastasis Rev, 17, 195–202.

    Article  PubMed  CAS  Google Scholar 

  • Yu, D., Jing, T., Liu, B., Yao, J., Tan, M., McDonnell, T.J., and Hung, M.C. (1998b). Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cipl, which inhibits p34Cdc2 kinase. Mol Cell, 2, 581–591.

    Article  PubMed  CAS  Google Scholar 

  • Yu, D., Liu, B., Jing, T., Sun, D., Price, J.E., Singletary, S.E., Ibrahim, N., Hortobagyi, G.N., and Hung, M.C. (1998c). Overexpression of both p185c-erbB2 and p170mdr-l renders breast cancer cells highly resistant to taxol. Oncogene, 16, 2087–2094.

    Article  PubMed  CAS  Google Scholar 

  • Yu, D., Matin, A., Xia, W., Sorgi, F., Huang, L., and Hung, M.C. (1995). Liposome-mediated in vivo E1A gene transfer suppressed dissemination of ovarian cancer cells that overexpress HER-2/neu. Oncogene, 11, 1383–1388.

    PubMed  CAS  Google Scholar 

  • Yu, D., Shi, D., Scanlon, M., and Hung, M.C. (1993a). Reexpression of neu-encoded oncoprotein counteracts the tumor-suppressing but not the metastasis-suppressing function of E1A. Cancer Research, 53, 5784–5790.

    PubMed  CAS  Google Scholar 

  • Yu, D., Suen, T.C., Yan, D.H., Chang, L.S., and Hung, M.C. (1990). Transcriptional repression of the neu protooncogene by the adenovirus 5 E1A gene products. Proc Natl Acad Sci USA, 87, 4499–4503.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Yu, D., Wolf, J.K., Scanlon, M., Price, J.E., and Hung, M.C. (1993b). Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A. Cancer Res, 53, 891–898.

    PubMed  CAS  Google Scholar 

  • Yu, D.H., and Hung, M.C. (1991a). Expression of activated rat neu oncogene is sufficient to induce experimental metastasis in 3T3 cells. Oncogene, 6, 1991–1996.

    PubMed  CAS  Google Scholar 

  • Yu, D.H., Liu, B.L., Tan, M., Li, J.Z., Wang, S.S., and Hung, M.C. (1996). Overexpression of cerbb-2/neu in breast cancer cells confers increased resistance to taxol via MDR-1-independent mechanisms. Oncogene, 13, 1359–1365.

    PubMed  CAS  Google Scholar 

  • Yu, D.H., Scorsone, K., and Hung, M.C. (1991b). Adenovirus type 5 E1A gene products act as transformation suppressors of the neu oncogene. Mol Cell Biol, 11, 1745–1750.

    PubMed  PubMed Central  CAS  Google Scholar 

  • Zhang, Y., Yu, D., Xia, W., and Hung, M.C. (1995). HER-2/neu-targeting cancer therapy via adenovirus-mediated E1A delivery in an animal model. Oncogene, 10, 1947–1954.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Box 79, 1515 Holcombe Boulevard, Houston, Texas, 77030, USA

    M. C. Hung

  2. Section of Molecular Cell Biology Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Box 79, 1515 Holcombe Boulevard, Houston, Texas, 77030, USA

    M. C. Hung

  3. Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Box 79, 1515 Holcombe Boulevard, Houston, Texas, 77030, USA

    G. N. Hortobagyi

  4. Department of Blood and Marrow Transplantation, The University of Texas M. D. Anderson Cancer Center, Box 79, 1515 Holcombe Boulevard, Houston, Texas, 77030, USA

    N. T. Ueno

Authors
  1. M. C. Hung
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. N. Hortobagyi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. T. Ueno
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Imperial College School of Medicine, Hammersmith Hospital, London, UK

    Nagy A. Habib

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Hung, M.C., Hortobagyi, G.N., Ueno, N.T. (2002). Development of Clinical Trial of E1A Gene Therapy Targeting HER-2/neu-overexpressing Breast and Ovarian Cancer. In: Habib, N.A. (eds) Cancer Gene Therapy. Advances in Experimental Medicine and Biology, vol 465. Springer, New York, NY. https://doi.org/10.1007/0-306-46817-4_16

Download citation

  • DOI: https://doi.org/10.1007/0-306-46817-4_16

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-306-46191-0

  • Online ISBN: 978-0-306-46817-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation